Decitabine enhances targeting of AML cells by NY-ESO-1-specific TCR-T cells and promotes the maintenance of effector function and the memory phenotype

NY-ESO-1 is a well-known cancer-testis antigen (CTA) with re-expression in numerous cancer types, but its expression is suppressed in myeloid leukemia cells. Patients with acute myeloid leukemia (AML) receiving decitabine (DAC) exhibit induced expression of NY-ESO-1 in blasts; thus, we investigated...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Synat, Wang, Lixin, Xu, Lu, Wang, Ruiqi, Kang, Qingzheng, Gao, Xuefeng, Yu, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568428/
https://www.ncbi.nlm.nih.gov/pubmed/36097193
http://dx.doi.org/10.1038/s41388-022-02455-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568428/
https://www.ncbi.nlm.nih.gov/pubmed/36097193
http://dx.doi.org/10.1038/s41388-022-02455-y

Ejemplares similares